Rahav, Galia

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Maertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,001

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 192

BNT162b2 vaccination in heart transplant recipients: Clinical experience and antibody response

Peled, Y., Ram, E., Lavee, J., Sternik, L., Segev, A., Wieder-Finesod, A., Mandelboim, M., Indenbaum, V., Levy, I., Raanani, E., et al. (2021) · The Journal of Heart and Lung Transplantation

SARS-CoV-2 and COVID-19 ResearchTransplantation: Methods and Outcomes

Cited by 126

Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel

Regev-Yochay, G., Amit, S., Bergwerk, M., Lipsitch, M., Leshem, E., Kahn, R., Lustig, Y., Cohen, C., Doolman, R., Ziv, A., et al. (2021) · The Lancet Regional Health - Europe

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 111

Severe infections in thalassaemic patients: prevalence and predisposing factors

Rahav, G., Volach, V., Shapiro, M., Rund, D., Rachmilewitz, E. A., & Goldfarb, A. (2006) · British Journal of Haematology

Hemoglobinopathies and Related DisordersIron Metabolism and Disorders

Cited by 79

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Pappas, P. G., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., Mccarty, T., Thompson, G. R., et al. (2023) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 65

Delayed diagnosis of colorectal sexually transmitted diseases due to their resemblance to inflammatory bowel diseases.

Levy, I., Gefen-Halevi, S., Nissan, I., Keller, N., Pilo, S., Wieder-Finesod, A., Litchevski, V., Shasha, D., Kedem, E., & Rahav, G. (2018) · International Journal of Infectious Diseases

Reproductive tract infections researchSyphilis Diagnosis and Treatment

Cited by 37

147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

Pappas, P., Kullberg, B. J., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., McCarty, T. P., et al. (2020) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 17

First report of myocarditis in two patients with COVID-19 Omicron variant: case report

Fishman, B., Goitein, O., Berkovitch, A., Rahav, G., & Matetzky, S. (2022) · European Heart Journal - Case Reports

Viral Infections and Immunology ResearchCOVID-19 Clinical Research Studies

Cited by 12